The effects of hormone replacement therapy on endothelial function in women with Turner's syndrome

Clinical Endocrinology

Volumn 56, Issue 5, 2002, Pages 615-620

  Chan, N Norman ^a,b,c   Vallance, Patrick ^a   Colhoun, Helen M ^a   MacAllister, Raymond J ^a   Hingorani, Aroon D ^a   Conway, Gerard S ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MIDDLESEX HOSPITAL   (United Kingdom)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BRADYKININ; ESTRADIOL; ESTRADIOL VALERATE PLUS NORGESTREL; GLYCEROL NITRATE; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG INFUSION; FEMALE; FOREARM BLOOD FLOW; HORMONE SUBSTITUTION; HUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; TURNER SYNDROME; VASCULAR ENDOTHELIUM; VASODILATATION;

ADULT; AREA UNDER CURVE; BRADYKININ; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOREARM; HUMANS; NITRIC OXIDE SYNTHASE; NITROGLYCERIN; NOREPINEPHRINE; OMEGA-N-METHYLARGININE; REGIONAL BLOOD FLOW; TURNER SYNDROME; VASODILATOR AGENTS;

EID: 0036275415     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2002.01523.x     Document Type: Article

References (21)

1. Ethylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production
2. Measuring forearm blood flow and interpreting the responses to drugs and mediators
3. Estrogen replacement reverses endothelial dysfunction in postmenopausal women
4. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes
5. Insulin resistance: An early metabolic defect of Turner's syndrome
6. Changes in endothelium-dependent vasodilatation and alpha-adrenergic responses in resistance vessels during the menstrual cycle in healthy women
7. The impact of obesity on cardiovascular risk factors in Turner's syndrome
8. Undiagnosed morbidity in adult women with Turner's syndrome
9. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women
10. Acute vascular effects of estrogen in postmenopausal women
11. Morbidity in Turner syndrome
12. Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity
13. Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilatation
14. The protective effects of estrogen on the cardiovascular system
15. G-monomethyl-arginine attenuates the vasodilator action of bradykinin in the human forearm
16. Endogenous estrogen and acetylcholine-induced vasodilation in normotensive women
17. Mortality ratios, life expectancy, and causes of death in patients with Turner's syndrome
18. Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells. Effects on calcium sensitivity and NO release
19. Menopause is associated with endothelial dysfunction in women
20. Endothelial function and nitric oxide: Clinical relevance
21. Biology and clinical relevance of nitric oxide